IMARC Group’s latest research report, titled “Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the heparin market share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global heparin market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028.
Heparin Market Overview:
Heparin refers to a naturally occurring complex polysaccharide anticoagulant substance that is commonly used in medical settings to prevent blood clot formation. It is a highly sulfated glycosaminoglycan with a negative charge that is derived from mucosal tissues of animals, primarily porcine intestine or bovine lung. Heparin works by binding to antithrombin III (ATIII) protein and enhancing its inhibitory effect on clotting factors, thereby preventing the formation of blood clots. Additionally, it exhibits rapid action upon administration, with a relatively short duration of effect, and is delivered via injection either intravenously or subcutaneously.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/heparin-market/requestsample
Global Heparin Market Trends:
The global market is primarily driven by the increasing prevalence of chronic diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and myocardial infarction. In line with considerable rise in the geriatric population that is susceptible to developing these ailments is propelling product demand. Moreover, the rapid product utilization as an anticoagulant in increasing number of surgical procedures is also acting as a significant growth-inducing factor for the market. In addition to this, continual technological advancements in heparin extraction and purification techniques to facilitate reduced risk of contamination is creating a positive market outlook. Some of the other factors contributing to the market include rising healthcare expenditure, higher uptake of anticoagulant therapies, and extensive research and development (R&D) activities.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/heparin-market
Key Market Segmentation:
Top Heparin Companies Worldwide:
-
GlaxoSmithKline
-
Hepalink
-
Pfizer
-
LeoPharma
-
Sanofi
-
Reddy’s Laboratories
-
Teva Pharmaceutical Industries
-
Aspen
-
LEO Pharma
-
Baxter
-
Changshan Pharm
-
Sandoz
-
Opocrin
-
Deebio
-
Tiandong
Market Breakup by Product:
-
Unfractionated Heparin
-
Low Molecular Weight Heparin (LMWH)
-
Ultra-low Molecular Weight Heparin (ULMWH)
Market Breakup by Source:
-
Bovine
-
Porcine
Market Breakup by Mode of Administration:
-
Oral
-
Parenteral
Market Breakup by Application:
-
Atrial Fibrillation & Heart Attack
-
Stroke
-
Deep Vein Thrombosis (DVT)
-
Pulmonary Embolism (PE)
-
Others
Market Breakup by End-User:
-
Hospitals
-
Clinics
-
Homecare Settings
-
Ambulatory Surgical Centers
-
Others
Market Breakup by Distribution Channel:
-
Hospital Pharmacies
-
Retail Pharmacies
-
Drug Stores
-
Online Stores
-
Others
Breakup by Region:
-
North America (United States, Canada)
-
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
-
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
-
Latin America (Brazil, Mexico, Others)
-
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
+91 120 433 0800